AstraZeneca PLC AZN
186.23 USD -3.16 (-1.67%)
Nov 10, 2026, 1:51 PM EST
184.96 Day range 188.10
155.62 52-week range 209.48
- YTD
- +1.29%
- 1 year
- +6.44%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 58.74B | 54.07B | 45.81B | 44.35B | 37.42B | |
| 48.11B | 43.87B | 37.54B | 31.96B | 24.98B | |
| 13.74B | 10.00B | 8.19B | 3.76B | 1.06B | |
| 10.22B | 7.04B | 5.96B | 3.29B | 112.00M | |
| 6.54 | 4.50 | 3.81 | 2.11 | 0.08 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 5.71B | 5.49B | 5.84B | 6.17B | 6.33B | |
| 114.07B | 104.03B | 101.12B | 96.48B | 105.36B | |
| 65.36B | 63.16B | 61.95B | 59.42B | 66.08B | |
| 29.62B | 30.30B | 28.62B | 29.23B | 30.78B | |
| 48.67B | 40.79B | 39.14B | 37.04B | 39.27B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.57B | 11.86B | 10.35B | 9.81B | 5.96B | |
| -6.81B | -7.98B | -4.06B | -2.96B | -11.06B | |
| -7.54B | -4.00B | -6.57B | -6.82B | 3.65B | |
| -2.80B | -1.87B | -1.23B | -809.00M | -1.08B | |
| 223.00M | -115.00M | -286.00M | 25.00M | -1.45B |